11 insiders reported 48 Form 4 transactions for Monopar Therapeutics (MNPR) over the past 18 months (most recent 2026-04-02). Recent activity: Robinson Chandler (Chief Executive Officer) Buy 6,732 shares, Cittadine Andrew (Chief Operating Officer) Buy 3,514 shares, Robinson Chandler (Chief Executive Officer) Sell 1,972 shares, Cittadine Andrew (Chief Operating Officer) Sell 1,571 shares, Robinson Chandler (Chief Executive Officer) Buy 62,815 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | Robinson Chandler | Chief Executive Officer | Buy | 6,732 | $0 |
| 2026-04-02 | Cittadine Andrew | Chief Operating Officer | Buy | 3,514 | $0 |
| 2026-04-02 | Robinson Chandler | Chief Executive Officer | Sell | 1,972 | $108,046 |
| 2026-04-02 | Cittadine Andrew | Chief Operating Officer | Sell | 1,571 | $86,075 |
| 2026-01-30 | Robinson Chandler | Chief Executive Officer | Buy | 62,815 | $0 |
| 2026-01-05 | Robinson Chandler | Chief Executive Officer | Sell | 2,558 | $167,037 |
| 2026-01-05 | Cittadine Andrew | Chief Operating Officer | Sell | 1,889 | $123,352 |
| 2026-01-05 | Robinson Chandler | Chief Executive Officer | Buy | 8,724 | $0 |
| 2026-01-05 | Cittadine Andrew | Chief Operating Officer | Buy | 4,326 | $0 |
| 2025-12-29 | Vu Quan Anh | Chief Financial Officer | Buy | 1,500 | $104,925 |
| 2025-12-19 | KLAUSNER ARTHUR J | Director | Sell | 4,660 | $312,500 |
| 2025-12-19 | KLAUSNER ARTHUR J | Director | Sell | 461 | $31,389 |
| 2025-12-17 | KLAUSNER ARTHUR J | Director | Buy | 7,710 | $0 |
| 2025-12-17 | Hendricks Diane | Insider | Sell | 43,499 | $0 |
| 2025-10-02 | Robinson Chandler | Chief Executive Officer | Buy | 8,726 | $0 |
| 2025-10-02 | Robinson Chandler | Chief Executive Officer | Sell | 2,646 | $216,099 |
| 2025-10-02 | Cittadine Andrew | Chief Operating Officer | Buy | 4,327 | $0 |
| 2025-10-02 | Cittadine Andrew | Chief Operating Officer | Sell | 1,896 | $154,846 |
| 2025-09-26 | Brown Michael J | Insider | Sell | 550,229 | $35.0M |
| 2025-09-26 | Robinson Chandler | Insider | Sell | 550,229 | $35.0M |
| 2025-09-26 | Tactic Pharma LLC | Chief Executive Officer | Sell | 550,229 | $35.0M |
| 2025-09-26 | Mazar Andrew Paul | Insider | Sell | 550,229 | $35.0M |
| 2025-09-26 | O'Halloran Thomas V. | Insider | Sell | 550,229 | $35.0M |
| 2025-07-16 | Tsuchimoto Kim R | Director | Sell | 8,904 | $356,160 |
| 2025-07-16 | Tsuchimoto Kim R | Director | Buy | 8,904 | $89 |
Source: SEC Form 4 filings · as of 2026-04-02
